Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients with Dyslipidemia: A Randomized, Add-on Placebo-Controlled Clinical Trial.
Rituparna MaitiRashmi Ranjan MohantyAnupam DeyShampa MajiMilan PadhanArchana MishraPublished in: Journal of the American Nutrition Association (2023)
Add-on VCO (1000 mg/day) with atorvastatin (10 mg/day) can achieve a better clinical outcome in patients with dyslipidemia by increasing HDL and improving oxidative stress cardiovascular risk indices.
Keyphrases
- clinical trial
- double blind
- placebo controlled
- oxidative stress
- phase ii
- study protocol
- phase iii
- dna damage
- open label
- ischemia reperfusion injury
- randomized controlled trial
- fatty acid
- diabetic rats
- induced apoptosis
- phase ii study
- squamous cell carcinoma
- rectal cancer
- heat shock
- heat shock protein
- endoplasmic reticulum stress